Italy’s Sunshine Act, Answered: AI Tools, IT Integrations, and Research Benefits FAQ

Italy’s Sunshine Act (Law No. 62/2022) keeps generating questions as life sciences companies find new ways to support healthcare professionals and organizations, from AI-powered clinical tools to funded research collaborations. Below, we have rounded up recent expert-answered questions on where the reporting line falls, drawn directly from the most frequently asked questions related to the Italian Sunshine Act and Sanità Trasparente. If your compliance team is still mapping which transfers of value need to be published, these answers are a useful starting point.

Do AI modules bundled into a larger platform still need to be reported?

Yes. When a platform includes AI-driven decision-support or automation features for healthcare professionals or facilities, and those features are offered free or on especially favorable terms, that counts as a transfer of value under Article 3, paragraph 1. Bundling doesn’t create an exemption: if the AI component’s value can be separated out, it should be published on its own; if it can’t, the full package value gets published under the relevant category, and the overall benefit still has to be disclosed. Article 3, paragraph 2 may also come into play if the AI tool is delivered under a research or consultancy agreement.

Are IT integrations for clinical planning systems a reportable benefit?

Yes. If a manufacturer gives a healthcare organization or professional digital tools or system integrations — say, something that improves clinical planning or patient flow — at no cost, that is a transfer of value in goods or services. It must be published under Article 3, paragraph 1, as long as the recipient is identifiable and the benefit can be quantified, typically by valuing the added licensing, implementation, or service costs per Article 3, paragraph 4(e). Article 3, paragraph 2 generally only applies if the integration is delivered through a research or consultancy contract.

Is free access to language courses for scientific publishing disclosable?

Yes. Covering or waiving the cost of language training that supports a healthcare professional’s publications or research can constitute a benefit subject to disclosure under Article 3, provided the statutory conditions and applicable thresholds are met.

Does sabbatical funding need to be reported if there’s no guaranteed deliverable?

Yes. The absence of a required output doesn’t reduce the value of the transfer. Funded leave or scholarships benefiting healthcare professionals can constitute reportable transfers of value, subject to the applicable statutory conditions and thresholds.

Do virtual, multi-session mentoring programs count under Article 3?

Yes. Format does not matter here, virtual or in-person, single session or multi-session. A structured mentoring programme is generally built around an agreement or arrangement, and where that agreement falls within the relationships covered by Article 3, it may need to be communicated and published

Are consulting fees paid to retired physicians still reportable?

Yes, in most cases. Retirement does not automatically remove an individual from the scope of the law. The relevant question is whether the individual continues to fall within the definition of a person operating in the health sector under Law 62/2022 (for example, remains licensed or registered with their professional Order, still practices in healthcare, or can influence prescribing, purchasing, or usage decisions) and receives a reportable benefit.

Do virtual co-lab collaborations count as research benefits?

It can be reportable. Where an HCP or healthcare organization receives tools, compensation or funded access to digital infrastructure from a manufacturer, even indirectly, the benefit may constitute a reportable transfer of value. Where the arrangement forms part of a research agreement covered by Article 3, paragraph 2, the agreement itself may also be subject to disclosure.

The takeaway

Across these answers, a pattern holds: how a benefit is packaged, delivered, or labeled rarely changes whether it is reportable. What matters is whether a transfer of value moved to an identifiable healthcare professional or organization, and whether that value can be quantified. AI tools, software integrations, training, leave, mentoring, and research infrastructure can all create reportable transfers of value, depending on the nature of the benefit, the recipient and the applicable provisions of Article 3.

For life sciences companies operating across multiple EU markets, that means transfer-of-value tracking needs to reach beyond the obvious categories- sponsorships, consulting fees, travel- to digital and in-kind benefits that are easy to overlook until an audit or a Sanità Trasparente query surfaces them.

Have a question of your own?

Explore more FAQs on the Italian Sunshine reporting website, or ask our experts directly for guidance on how Law 62/2022 applies to your specific transfer of value.